2Moe, S., et al. Definition, evaluation, and classifi cation of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO [J]). Kidney Int, 2006, 69(ii): 1945-1953.
3Block, G.A., et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis[J]. J Am Soe Nephrol, 2004,15(8): 2208-2218.
4Hruska, K.A., et al. Renal osteodystrophy, phosphate homeostasis, and vascular calcification[J]. Semin Di- al, 2007,20(4): p. 309-315.
5Sakaguchi, T. and T. Akizawa, [K/DOQI clinical practice guidelines for bone metabolism and disease in CKDEJ]. Clin Calcium, 2004, 14(9): 9-14.
6Braun, J., et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic di- alysis patients[J].Am J Kidney Dis, 1996,27(3):394-401.
7Kalantar-Zadeh, K., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients[J].Kidney 1nt, 2006,70(4):771-780.
8Block, G.A., et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study[J]. Am J Kidney Dis, 1998,31(4): 607-617.
9Palmer, S.C., et al. Serum levels of phosphorus, para- thyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kid- ney disease: a systematic review and meta-analysis[J]. JAMA, 2011, 305(11): 1119-1127.
10Almaden, Y., et al. High phosphate level directly stim- ulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro[J]. J Am Soc Nephrol, 1998,9(10) t iB45-1852.
